about
High-throughput sequencing revealed a novel SETX mutation in a Hungarian patient with amyotrophic lateral sclerosis.Adiponectin levels in the serum and cerebrospinal fluid of amyotrophic lateral sclerosis patients: possible influence on neuroinflammation?Perception of Emotional Facial Expressions in Amyotrophic Lateral Sclerosis (ALS) at Behavioural and Brain Metabolic Level.The Awaji criteria increases the diagnostic sensitivity of the revised El Escorial criteria for amyotrophic lateral sclerosis diagnosis in a Chinese populationDihuang Yinzi, a Classical Chinese Herbal Prescription, for Amyotrophic Lateral Sclerosis: A 12-Year Follow-up Case Report.Identification and outcomes of clinical phenotypes in amyotrophic lateral sclerosis/motor neuron disease: Australian National Motor Neuron Disease observational cohort.Immununochemical Markers of the Amyloid Cascade in the Hippocampus in Motor Neuron Diseases.Pathological TDP-43 changes in Betz cells differ from those in bulbar and spinal α-motoneurons in sporadic amyotrophic lateral sclerosis.Functional reorganization during cognitive function tasks in patients with amyotrophic lateral sclerosis.Epidemiology of amyotrophic lateral sclerosis in Southern Germany.Efficacy of Stem Cell Therapy in Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis.Management and therapeutic perspectives in amyotrophic lateral sclerosis.The concept and diagnostic criteria of primary lateral sclerosis.FIG4 variants in central European patients with amyotrophic lateral sclerosis: a whole-exome and targeted sequencing study.Predictive genetic testing for amyotrophic lateral sclerosis and frontotemporal dementia: genetic counselling considerations.Autoantibody pathogenicity in a multifocal motor neuropathy induced pluripotent stem cell-derived model.A large-scale multicentre cerebral diffusion tensor imaging study in amyotrophic lateral sclerosis.A first approach to a neuropsychological screening tool using eye-tracking for bedside cognitive testing based on the Edinburgh Cognitive and Behavioural ALS Screen.Experience matters: neurologists' perspectives on ALS patients' well-being.Skeletal Muscle Remodelling as a Function of Disease Progression in Amyotrophic Lateral Sclerosis.Genetic and clinical analysis of spinocerebellar ataxia type 36 in Mainland China.Edaravone: a baby in the bathwater?Fast progressive lower motor neuron disease is an ALS variant: A two-centre tract of interest-based MRI data analysis.Motoneuron Disease: Clinical.Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria.Longitudinal Diffusion Tensor Imaging-Based Assessment of Tract Alterations: An Application to Amyotrophic Lateral Sclerosis.Observational study of patients in Spain with amyotrophic lateral sclerosis: correlations between clinical status, quality of life, and dignity.Anterior Cingulate Cortex TDP-43 Pathology in Sporadic Amyotrophic Lateral Sclerosis.Late age onset of amyotrophic lateral sclerosis is often not considered in elderly people.Pathological and immunoblot analysis of phosphorylated TDP-43 in sporadic amyotrophic lateral sclerosis with pallido-nigro-luysian degeneration.A case series of PLS patients with frontotemporal dementia and overview of the literature.Terminal latency abnormality in amyotrophic lateral sclerosis without split hand syndrome.Ptosis and bulbar onset: an unusual phenotype of familial ALS?Region-specific impairment of the cervical spinal cord (SC) in amyotrophic lateral sclerosis: A preliminary study using SC templates and quantitative MRI (diffusion tensor imaging/inhomogeneous magnetization transfer).Disease-modifying and symptomatic treatment of amyotrophic lateral sclerosis.Mecasin treatment in patients with amyotrophic lateral sclerosis: study protocol for a randomized controlled trial.Differential expression of microRNAs and other small RNAs in muscle tissue of patients with ALS and healthy age-matched controls.Identical patterns of cortico-efferent tract involvement in primary lateral sclerosis and amyotrophic lateral sclerosis: A tract of interest-based MRI study.Brain Structural and Perfusion Signature of Amyotrophic Lateral Sclerosis With Varying Levels of Cognitive Deficit.Amyotrophic lateral sclerosis
P2860
Q33562187-90DEFA55-B242-4D79-B895-AA0BFF91DE29Q33582007-E50D5810-E6DC-4100-A9D8-3991DE3BCF28Q36163860-A32F0117-7AC5-4B14-8C47-F353424316C0Q36293991-994D59E0-DFB7-4943-8087-9B52971B0098Q37206849-4D8517C2-CFC6-47BD-A432-44FF5DF989B9Q37312624-272DF0A2-52BD-4849-9C86-D22DB7A8CD78Q37398778-6D263B27-9CA6-4E61-980A-33EA32BA59F2Q37553471-1054978B-382D-4704-8EEA-09C51905A032Q38672593-A061B15E-B98D-49B1-9E8B-D74946BC2B8DQ38755154-54FCE338-B47D-4FD6-B34E-B0150F1F0CD8Q38777893-A0181B71-6EDA-4857-95CE-44AE77665883Q38958585-F5AECD67-1349-4698-961F-8133B9D6A3F0Q39012146-98BB07B5-FCE2-40A2-BBA0-C85962C6B5ACQ39041490-D2AFF713-C2F1-409A-8E2A-16D8ECF44A0BQ39354046-4F1DE7E3-439D-47EC-A320-9D75606B9984Q39808275-7EB667E1-BA7F-4ED1-B9C9-FC685F070636Q40128196-45564EC5-E713-4151-9179-691CF9B6ACEBQ40237885-53658B1B-75E0-4931-B5C1-EEEC85376B81Q40365742-11FCC962-4229-4334-BE86-6A3A65AE4E4EQ40852587-43C75198-104C-4B00-ACBE-0CB571E41297Q41055686-872CAA05-ED05-4E87-A95C-F07E8E18CEEDQ42345783-7B9DCDD2-B72E-4BC3-878F-E18059C1FA26Q42654900-D2752C74-1EE7-468F-A804-C2C0E57F4F67Q45869420-DE34743B-FE59-4D63-A708-428743D47D66Q46130574-8B40C026-DB2B-4E92-A61B-77D388E62E9AQ47151321-CA3A3F95-2EAF-4CAA-9DFE-FC72D5C921C7Q47159772-FD1FF861-24DD-4133-AECB-0EADEC9C29C5Q47351963-AAF4F8B5-A4CE-4675-941E-6EF98E4F7D29Q47580729-D3C85C59-923E-448E-99E2-0917F56E1508Q47773427-ADA93F20-B8CC-4235-82F1-9B0A33B9AE3CQ48179002-9C82A5ED-DD11-4866-A207-F471A7141113Q48250780-1BD12E6B-C44B-4B7C-9CC8-39381061B3D5Q48310586-F509E9B6-EF59-48BA-BF90-B9A3B841AF8AQ48323658-C8D5B19D-872B-4348-8435-CE47CD4B763EQ49335981-DFE842C7-68EF-440C-8FE2-2EA875B7E462Q52589536-A743EDC6-D802-4D6B-8749-AD1C200B7F80Q52721505-3EAC59AF-3E0D-4BF8-9FF2-AA6DE17C2D98Q54989554-827222EC-4D23-4147-863A-53CC249970CAQ55312987-2A241B26-3E64-40D7-847D-A30F0C875543Q56531747-F9CA8E71-2DEF-4657-8C63-A67089B7CB11
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
A revision of the El Escorial criteria - 2015.
@en
A revision of the El Escorial criteria - 2015.
@nl
type
label
A revision of the El Escorial criteria - 2015.
@en
A revision of the El Escorial criteria - 2015.
@nl
prefLabel
A revision of the El Escorial criteria - 2015.
@en
A revision of the El Escorial criteria - 2015.
@nl
P2093
P50
P1476
A revision of the El Escorial criteria - 2015.
@en
P2093
Imaharu Nakano
Jeremy Shefner
John Ravits
Vivian Drory
WFN Research Group On ALS/MND
P304
P356
10.3109/21678421.2015.1049183
P577
2015-06-29T00:00:00Z